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Abstract
Background Achilles tendons heal slower than other tis-
sues, therefore requiring the developmnent of a strategy for
accelerating the process. Vascular supply plays an impor-
tant role in primary tendon healing, especially during
the early healing phase. MicroRNA (miR)-210 has been
reported as being crucial for angiogenesis, which is a key
factor of tissue repair. We report herein that local injection
of synthetic miR-210 into the injured Achilles tendon of a
rat accelerated healing of the tendon.
Methods Achilles tendons were transected and repaired
via the Kessler suture technique in Sprague-Dawley rats'
Then, double stranded (ds) miR-210 was injected into the
repaired sites. The control group was injected with non-
functioned dsRNA. At2,6 and 12 weela, histological eval-
uations were performed. At two and six weeks, mechanical
testing and angiogenesis were evaluated. Gene expression
analysis using real-time polymerase chain reaction (PCR)
and immunohistochemistry were performed at two weeks.
Result At two and six weeks, regular dense collagen tis-
sue in the miR-210 group was observed and the diameter
of collagen fiber in the miR-210 group was significantly
higher than in the control. At two weeks, the ultimate
failure load was significantly higher than in the control
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group, and expression of VEGR FGF2 and fype I collagen
was upregulated. Abundant vessels in the miR-210 group
were observed at two weeks, but there was no significant
difference in vessel numbers between the two grouPs at
six weeks. At 12 weela, repaired Achilles tendons in the
miR-210 group consisted of parallel and dense fibers,
whereas wavy and loose fibers were still observed in the
control group.
Conclusion The current study showed that single local
injection of synthetic miR-210 promotes Achilles tendon
healing in the earlY Phase.
Introduction
Achilles tendon injury is a very corlmon injury in the
onhopaedic field, usually due to trauma or sport injury Il].
However, its optimal treatrnent is still debatable in spite
of the high rupture incidence. Several reports comparing
operative treatrnent to non-operative treatment focused
on the rate of re-rupture and complications. Some papers
demonstrated that non-operative treatment resulted in a
higher incidence of re-rupture [24], while no significant
difference in the re-rupture rate between non-operative
and operative treatrnent was reported in several papers [5'
61. The most important aspect of Achilles tendon injury is
that they heal at a slower rate than other connective tissues
because of the reduced cellular component of the tendon
tissue. Therefore, various studies have attempted to acceler-
ate Achilles tendon healing using drugs, cytokinei irnd cell
therapy [7-9],
MicroRNAs (miRNAs) are small non-coding RNA
molecules that are well known as important key play-
ers in a variety of biological processes. miRNAs nega-
tively regulate gene exPression by inhibiting translation
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or degradation of mRNA (messenger RNA) through the
binding the 3' untranslated region (3' UTR) of their target
mRNA tl0-131. miRNA plays an important role in the
pathogenesis of many human diseases' Therefore, several
therapeutic trials regulating endogenous miRNA in vivo
have been conducted U,t-161. miRNA also plays a crucial
role in the pathogenesis of disease or trauma in locomotor
organs [17-21]. As we known, vascular supply in tendons
is very limited and is significantly reduced after injury or
rupture. We believe angiogenesis activation of endothelial
cells may play an important role in promoting and regulat-
ing other biological events that can increase vascular per-
meability in the tendon healing process' MiRNA (miR)-210
is capabile of inducing angiogenesis by targeting ephrin-
A3 (EFNA3) [22]. miR-210 is upregulated in'response to
hypoxia, which affects cell survival, migration, and differ-
entiation. Moreover, overexpression of miR-210 enhances
the formation of capillary-like structures 123,241. There-
fore, our hypothesis is that administration of miR-210 can
enhance tendon healing via acceleration of angiogenesis in
an early phase, which will subsequently promote matura-
tion of the Achilles tendon. The purpose of this study is to
examine the therapeutic effect of a single administration of
miR-210 into the ruptured Achilles tendon in a rat model.
Materials and methods
Animal model
This study was reviewed. and approving by the Ethics Com-
mittee for Experimental Animals of Hiroshima Upiversity
and the animals were treated according to the guidelines of
the Institutional Animal Care and Use Committee.
Male 12-week-old Sprague-Dawley rats weighing
200-250 g were used in this study. The rats were housed
under standard conditions at the Laboratory Animal Cen-
tre at the Hiroshima University. They were fed a standard
commercial diet and water. The injured Achilles tendon
model was created according to the previous report Fl,
Under general anesthesia, a 3-cm longitudinal skin inci-
sion was made over the Achilles tendon of the right leg'
The sunounding fascia was cut longitudinally, and the
Achilles tendon and plantaris tendon were exposed. The
Achilles tendon was cut transversely 5 mm from its cal-
caneal insertion. The Achilles tendon was repaired with
7-0 monofilament nylon sutures using a modified Kessler-
type suture technique. The plantaris tendon was preserved.
The wound was closed with 5-0 monofilament nylon
sutures. After surgery, 30 pl of atelocollagen (Koken,
Tokyo, Japan)/double stranded (ds) RNA (atelocolla-
gen 15 p,l; dsRNA 20 pg) was injected percutaneously
into the repaired tendon (Fig. 1). Ds miR-210 (sequences
Q Springer
Fig. 1 Experimental procedurc scheme
66-CUG-UGC-GUG-UGA-CAG-CGG-CUG-A-87 and
87-AGC-CCC-UGC-CCA-CCG-CAC-ACU-G-66 labeled
with FAM, B-Bridge International) was injected into the
repaired tendon site in the miR-210 group, and non-func-
tional ds RNA (siRNA negative control, B-bridge Inter-
national; ds Nega) was injected in the control group. The
rats without any ds RNA injection after surgery were also
evaluated as the non-injection group. The rats were placed
in their cages and afforded unrestrained mobility. Ar 24 h'
3 days, and 2, 6 ud 12 weeks after operation all rats were
killed by overdose injection of anesthesia' The Achil-
les tendon was rsmoved with the attached calcaneal bone
and dissected from other surrounding tissue and prepared
for histological evaluation, gene expression analysis, and
mechanical testing. Five rats in each group were used to
test tensile strengths, and five other rats were used to test
gene expression. The remaining rats in each group were
used for histological evaluation.
Histological analysis
At 2, 6 and 12 weeks after sugery 5 rats in each group
at each time point were sacrificed. Then, Achilles tendons
were harvested and quickly embedded in Tissue Freezing
Medium (Triangle Biomedical Sciences, Durham, NC,
USA), snap-frozen in liquid nitrogen. Sections 6 pm thick
were prepiued and Masson trichome staining llhs per-
formed. The specimens were examined in a random order
with a microscope and two observers (MAU, TS) evalu-
ated the specimens according !o an arbitrary scoring system
from I to 5, where I represented an immature loose cal-
lus and 5 represented a dense organized fibrous tissue with
, dsRNNI t5ffr'f'*
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mostly parallel fibers, according to the previous report [21].
Five microscopic areas from each specimen at x200 mag-
nification were randomly chosen and the diameter of newly
formed collagen fiber was measured by the two authors
(MAU, TN) at two and six weeks using a digital micro-
scope (BZ-9000, Keyence, Japan),
To evaluate the distribution of the injected ds miRNA,
rats were sacrificed 24 h after injection and 6-pm serial sec-
tions were mounted on saline-coated glass slides, air-dried,
and fixed with 4.0 Eo paraformaldehyde at 4 oC for 5 min.
Then, 4/,6-diamidino-2-phenylindole (DAPI) solution was
applied for 5 min for nuclear staining. FAMJabeled miR-
210 in Achilles tendon specimens was detected using fluo-
rescence microscopy. 
:
Immunohistochemistry analysis
For immunohistochemistry staining of Isolectin 84, VEGF,
FGF2 and Collagen type I, specimens were fixed with
4.0 Vo paraformaldehyde at 4 "C for 5 min. After block-
ing by horse serum (Vector Laboratories, Bur- lingame,
California), specimens were stained with rabbit poly-
conal anti-VEGF or anti basic FGF antibody (Abcam,
Cambridge, Massachusetts, concentration 1:100), goat
polyelonal anti-collagen type I antibody (Santa Cruz Bio-
technology, Santa Cruz, California; concentration l:50),
or fluorescein-labeled GSL I-isolectinB4 (Vecror Labora-
tories, Burlingam, Califomia; concentration l:100) The
secondary antibodies used were Alexa Fluor 488-conjun-
gated or Alexa Fluor 568-conjungated goat anti-rabbit IgG
for VEGF and FGF2, 4nd Alexa 488-conjugared or Alexa
568-conjungated rabbit anti-goat IgG for collagen type I(all from Molecular Probes/Invitrogen, Carlsbad, Califor-
nia). DAPI solution was applied for 5 min to detect nuclear
staining. The negative control was prepared in the same
manner without the primary antibody. For evaluating newly
formed vessels, five microscopic areas (250 x 250 p,m)
from each specimen at x200 magnification were randomly
chosen. Capillaries were recognized as tubular structures
positive for isolectin 84, and counted by the two authors
(MAU, TN).
Mechanical testing
Per their gross appearance at fwo weeks, the Achilles tendon
For testing mechanical properties at two and six weeks, a surfaces in the control group were irregular and delle was
conventional tensile tester (1840 NT/500; AIKOH Engi- observed in the repaired site. On the other hand, repaired
neering, Osaka, Japan) was used. All of the extra soft tissue Achilles tendon surfaces in the miR-210 treated grnuf *.r.
and hard tissue was removed from the calcaneal or Achil- smoother and bulkier than in the control group. Histologi-
les tendon complex by blunt and/or sharp dissection. The cal analyses of Masson trichrome staining demonstrated
calcaneus-Achilles tendon complex was fixed between two that the injury site was filled by a dense organized fibrous
metal clamps and pulled at a constant speed of 200 mm/ tissue with mostly parallel fibers in the miR-210 group,
min vertically until rupture, The maximum load recorded while immature loose fibrous tissue was observed in the
was recognized as the ultimate tensile strength. In addition, control and non-injection groups (Fig, 2a). At six weeks,
the calcaneus-Achilles tendon complex from other normal
rats were measured as normal tendons.
Quantitative real-time PCR
Total RNA was isolated from repaired Achilles tendon site
using TRIzol. Complementary DNA was synthesized using
"Ready to Go You-Prime First-Strand Beads" (GE Health-
care, Chalfot, UK) with total RNA (l pg) and oligo (dT)
primers. For miRNA expression analysis, reverse tran-
scriptase reactions of mature miRNAs contained a sample
of total RNA, 50 nM of stemJoop RT primer, l0 x RT
buffer, 100 mM of each dNTP, 50 U/p,l of MultiScribe
Reverse Transcriptase, and 20 U/pl of RNase inhibitor.
15-pl reactions were incubated in a thermocycler (Bio-
Rad, Hercules, CA). Real-time quantitative PCR was car-
ried out using TaqMan Gene Expression Assay probes for
mo-miR-210, snoRNA-I35, VEGF, COLlA1, FGF2 and
ACTB. The expression levels for each gene were assessed
relative to the expression of snoRNA-l35 for miR-210,
and ACTB for other genes. A threshold cycle (C1) was
observed in the exponential amplification phase, and quan-
tification of relative expression levels was performed using
standard curves for target genes and the endogenous con-
trol. Geometric means were used to calculate the AAC-
(delta-delta C1) values and expressed as 2-aacr. The vaiue
of each control sample was set at one and used to calculate
the fold-change of target genes,
Statistical analysis
All results in this study were expressed as the
mean * standard deviation (SD), Comparison among the
three groups was done using the Ti.rkey-Kramer post hoc
test. A p value of <0.05 was consider statistically signifi-
cant. All data were c'alculated and shown as value *SD.
Results
Administration of ds miR-210 could enhance
morphological and functional recovery
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Fig,2 a Masson trichrome staining of repaired site in the non-injec-
tion, control and miR-210 groups at two and six weeks. Bars rcp'
resont IOO pm. b Collagen fiber diameter in all groups at two and
six weeks. *p < 0.05, c Distribution of FAMlabeled dsmiR-210 at
abundant collagen fibers with little fibrous tissue occupied
the injured site in the miR-210 group, while the abundant
'Ioose fibrous tissue still remained in the control and non'
injection groups (Fig, 2a). The histological score of the
miR-210 group (4.4 *0.2 points) was significantly higher
than the control (1.4 +0.2 points) and non-injection groups
(1.4 t0.5) at two weeks, and the histological score in the
miR-210 group was signif,cantly higher than that in the con-
trol and non-injection groups (non-injection group, 1.8 t0.8
points; control group, 1.8 +0.8 points; miR-210 group,
4.6 +0.5 points) at six weeks. The mean collagen fiber
diameter in the miR-210 group was significantly higher
than that in the control (non-injection group,2.4 *0.2 p,m;
control group, 2.5 *0.3 p.m; miR-210 group,4.0 t0.2 p,m)
(p < 0.05) at two weeks, and the mean collagen fiber in the
miR-210 group was significantly higher than that in the
controls (non-injection group,4.4 *0.4 U,m; control group,
4.2 t0.3 U"m; miR-210 group, 6.0 *0.3 p"m) (p < 0.05) at
six weeks (Fig. 2b). FAM-labeled dsmiR-210 was detected
in the tendon near the injured site and around the tendon
(Fig. 2c). The ultimate failure load of the Achilles tendon
in the miR-210 group (25.3 L73 N) was significantly
O Springer
24 h after injection. Arrows indicate FAMlabeled ds miR-210. Dot-
ted lines indicate the Achilies tendon outline. *Achilles tendon. Bars
represent 100 pm
2 w€gks 6 weeks
Fig.3 Mechanical rcsdng at two and six weeks. *p < 0.05. N,S no
significant diffcrencc
higher than that in the non-injection group (13.2 f 1.7 N)
and control group (14.6 +l'7 N) at two weeks after local
injection (p < 0.05) (Fig. 3). At six weeks, there was no
significant difference in the ultimate failure load between
both groups @ = 0.453), but the ultimate failure load in
the miR-210 group (73.0 +22.4 N) was likely to be higher
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than that in the non-injection (65.9 +17.3 N) and control
groups (70.4 +22,4N).In all groups, the failure site was the
repaired site in all specimens. These findings indicate that
single local injection of ds miR-210 could enhance morpho-
Iogical and functional recovery at two weeks.
To examine the effect of miR-210 administered on angi-
ogenesis during an early phase, immunohistochemistry of
isolectin 84 was performed. In thew miR-210 group, abun-
dant vessels in the repaired site were observed while there
were few newly-formed vessels in the non-injection and
control groups (Fig. 4a). The capillary density in miR-210
group was significantly higher than that in the non-injection
and control groups (non-injection group, 31.4 *5.3; con-
trol group, 32.6 *8.3; miR-210 group, 172.1 t12.7 captl-
Iary proflles per mm2, p < 0.05). Although miR-210 pro-
motes healing by angiogenesis during the early phase, there
was no significant diff,erence in the number of blood ves-
sels between all groups (non-injection group, 75.5 *4.3;
control group,76,2 *7.6; miR-210 group,84.5 *15.4 cap-
illary profiles per mm') at six weeks, indicating blood ves-
sel retraction during a subsequent remodeling phase, during
tendon maturation by miR-210 injection (Fig. ab).
Gene expression analysis
Firstly, the expression level of miR-210 at three days after
injection was evaluated by real-time PCR. The expression
of mature mo-miR-210 was significantly upregulated in the
miR-210 group compared to the non-injection and control
gropus (p < 0.05) (Fig. 5a). VEGR which is an important
factor of angiogenesis in the healing process, was upregu-
lated in the miR-210 grouP as compared to the non-injec-
tion and control groups (Fig. 5b). Also, expression of FGF2
and Collal in the miR-210 group was significantly higher
than in the non-injection and control groups (Fig. 5c, d).
The immunohistochemistry of VEGB FGF2 and type I
6 weeks
Fig, 4 a Immunohistochemistry of isolectin 84 at two and six weeks. Barr represent 100 pm. b The number of blood vessels in the non-injec-
!ion, control and miR-210 groups at two and six weels. *p < 0.05, tVS no significant difference
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Fig,5 Gene expression
analysis of miR-210, VEGFA
FGF2 and Collal by real-time
PCR three days after injection.
*p < 0.05
collagen two weeks after injection was more expressed at
the injured sites in the miR-210 group as compared to the
control group (Fig. 6).
Administration of ds miR-210 can promote maturation
of the Achilles tendon
At 12 weeks, repaired Achilles tendons in the miR_210
group consisted of parallel and dense fibers, whereas the
control group still exhibited wavy and loose fibers, alrhough
newly-formed collagen fibers in the Achilles tendon in both
groups were remodeled and had matured (Fig, 6).
Discussion
Vascular supply plays an important role in primary tendon
healing [26, 27]. Tendon healing undergoes three phase,
A Springer
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including an inflammatory phase, a proliferative phase, and
a remodeling phase [28]. During these phases, especially at
the early stage, blood supply provides not only cell infilua-
tion, including inflammatory cells and fibroblasts, but also
supplies reparative factors such as multiple growth factors,
oxygen, and so on. It is expected that the promotion of neo-
vascularization accelerates tendon healing by up-regulation
of endogenous reparative factors. Growth factors such as
VEGE TGF-pl, PDGF, and FGFZ also have multiple sig-
nificant roles in tendon healing [29]. During the tendon
healing process, each growth factor has a crucial func-
tion at different stages and work in cooperation lvith other
growth factors during such. Several studies have attempted
to improve the primary tendon healing process by apply-
ing exogenous growth factor in animal models, demonstrat_
ing enhanced tendon healing [7]. In most of these studies,
however, the application of a single growth factor was con-
ducted. The application of a single exogenous growth factor
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Fig. 6 Immunohistochemical analysis of VEGFA, FGF2 and type I collagen two weels after injection, Barrepresents 100 pm
might not be enough to further improve and accelerate
physiological tendon healing. Notably, one miRNA has a
hundred target genes estimated by computational, pnalysis,
meaning miRNA can regulate many gene networks simul-
taneously. This could be one of the advantages of miRNA
therapy. It has been reported that miRNA-210 plays a cru-
cial role in angiogenesis in response to hypoxia via target-
ing Ephrin-A3,82F3, NPTXI, RAD52, ACVRIB, MNT,
CASP8AP2, FGFRLI, and HOXA-I l2Z-241. Hu er al.
[28] demonstrated that local injection of ds miR-210 into
the myocardium improves cardiac function through angio-
genesis, inhibiting apoprosis. Shoji et al. [16] reported thar
intra-articular injection of ds miR-210 for partial rupture of
the anterior cruciate ligament accelerated ligament healing
in a rat model. In the orthopaedic field, reports of therapeu-
tic trials in vivo using several miRNAs have increased. It
has been reported that local injection of muscle-specific
miRNAs accelerates muscle regeneration in a rat muscle
injury model [21]. Systemic injection of miR-146a amelio-
rated joint destruction in a collagen-induced mouse model.
Masson trichrome staining revealed the collagen fibers in
the miR-210 treated group become more aligned and denser
than that in the control group at two weeks. In immuno-
histochemistry analysis of type I collagen, the synthesis of
type I collagen in the miR-2lO-treated group was higher
than that in the control group, which usually begins at
about six weeks, during the remodeling phase. In previous
reports, TGF-PI promoted collagen synthesis in repaired
Achilles tpndons in rats, subsequently increasing the ten-
sile strength at two and four weela [30]. Our mechan!
cal testing results- showed that administering ds miR-210
increased the tensile strength in the repaired Achilles ten-
don at two weeks after surgery. Improvement during the
early phase of primary tendon healing has become more
and more important since several clinical studies have indi-
cated the benefit of early mobilization after surgery. The
most significant result of the present study, therefore, is
that local injection of ds miR-210 into an injured Achilles
tendon can give rise to higher tensile strength and aid the
histological healing process of advanced tissue during the
early phase, leading to more matue Achilles tendon heal-
ing at six weeks (Fig. 7).
Tendons are largely avascular. The in-growth of ves-
sels contributes to tendon repair during the early phase but
over-vasculature in the tendon may cause chronic tendi-
nopathy. In our results, abundant blood vessels at the repair
site in the miR-210 group were observed, but the blood
vessels retracted during the subsequent remodeling phase,
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Fig,7 Masson trichrome stain-
ing at 12 weeks in the control
and miR-210 groups. Bars in
the upper column tgpresent
200 pm and those in rhe lower
columnrepresent 100 pm
indicating that single local injection of as min-ZtO did not
induce lasting over-vasculature, resulting in impaired ten_
don function. Blood vessel retraction during the latter phase
may be due to the acceleration of remodeling induced by
miR-210 injection.
There are several limitations to this study. First, it is
unclear what kind of cells miR-210 affect. FAMlabeled
miR-210 was detected in the tendon and surrounding tis_
sue. It has been reported that miR_210 can function in the
endothelial cells, Therefore, miR-210 might be taken up in
the endothelial cells around the repaired tendon site, and
there was a possibility that miR_210 might work in fibro-
blasts in the tendon. Second, the precise molecular mecha_
nism by which miR-210 enhances Achilles tendon healing
has not been elucidated. In our study, VEGF and FGF2,
which play important roles in angiogenesis, were upregu_
lated by miR-210, and the acceleration of tendorl healing
might enhance collagen type I synthesis. However, its pro_
cess, including changing the expression pattem of miR_210
target genes, could not be elucidated. miRNAs have hun_
dreds of target gene, as determined by computational analy_
sis. Therefore, it is challenging to elucidate the mechanism
completely. These results suggest that administrated miR_
210, which was taken up or which upregulated the expres_
sion of the endogenous miR_210 in the injured Achilles
tendon, could have upregulated VEGF and FGF2 expres-
sion, and subsequently induced type I collagen, which is
a main functional component of tendons during the early
tendon healing phase. Finally, there was u porr-iUitiry *,ut
the non-specific response, such as an unexpected vascu_
lar or immune response to the injected synttretlc miR_210,
could of enhanced Achilles tendon healing. However, we
created a non-RNA injection control model and it exhibited
the same results of non-speciflc, functional ds RNA, Thesedata and the previous report of Shoji et al. suggest that
miR-210 injection had a specific effect on enhancement ofAchilles tendon healing.
0 Springer
In conclusion, our study shows the potential of adminis_
tering ds miR-210 for the acceleration of tendon repair. It
is speculated that miR-210 accelerates neovascularization
and, consequently, induces a microenvironment conducive
to tendon healing during the early phase. Nevertheless,
the details of this mechanism remain unclear. Single local
injection of ds miR-210 may become a new therapeutic
strategy for promoting tendon healing.
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